Similar to the analyses of cDC1 and NK cell gene signatures, we observed a positive correlation with survival when we ranked melanoma, HNSC and TNBC patients according to expression of CCL5, XCL1, and XCL2 (Figures S7D and S7E). The gene discussed is XCL2; the disease is melanoma.